Differences in color vision impairment caused by digoxin, digitoxin, or pengitoxin.
Color discrimination ability of 53 patients with congestive heart failure and 32 healthy volunteers treated with digoxin, digitoxin, or pengitoxin was determined with the Farnworth's Munsell 100 hue test. The patients had been treated with digitalis glycosides for several months prior to color vision testing. The volunteers received glycosides until a steady-state plasma concentration was reached. Glycoside plasma levels were measured by radioimmunoassay on the 3 days prior to color vision testing. The total error scores, indices of color discrimination, increased with the glycoside plasma levels. Subjects treated with digitoxin or pengitoxin exhibited no marked elevation in total error score at therapeutic concentrations, whereas 17 of 28 subjects with therapeutic digoxin plasma concentrations (less than 2.0 ng/ml) showed disturbed color discrimination. At toxic plasma levels all 5 digoxin-treated subjects, 7 of 13 digitoxin-treated subjects, and 3 of 8 pengitoxin-treated subjects showed impairment of color discrimination. The greater tendency of digoxin to impair color vision in comparison with digitoxin and pengitoxin may be related to a higher uptake or different distribution in the retina.
D000113:Acetyldigoxins / Q000009:adverse effects / Q000097:blood; D000328:Adult; D003118:Color Perception / Q000187:drug effects*; D004071:Digitalis Glycosides / Q000009:adverse effects*; D004074:Digitoxin / Q000009:adverse effects / Q000097:blood; D004077:Digoxin / Q000009:adverse effects / Q000097:blood; D005260:Female; D006801:Humans; D007700:Kinetics; D008297:Male; D008875:Middle Aged
D000113:Acetyldigoxins; D004071:Digitalis Glycosides; C016034:pentaacetylgitoxin; C025972:16-acetylgitoxin; D004077:Digoxin; D004074:Digitoxin